FCPA – Policy & Medicine

Novartis Resolves FCPA Investigations

Alexion Reaches Agreement in Principle with SEC Over FCPA Violations

Christmas Comes Early – The FCPA Pilot Program Made Permanent

To Disclose or Not to Disclose… That is the Question: The DOJ’s FCPA Pilot Program – Insights from Year One and Beyond

TEVA – Using Legitimate Distributor Payments to Conceal Bribes

Zimmer Biomet Pays $30 Million to Resolve New FCPA Charges

The Trump Administration: One Predictive Perspective

Teva Pharmaceutical to Pay $519 Million to Settle FCPA Charges

AstraZeneca Pays $5.5 Million to Resolve FCPA Offenses

Is the Carrot Bigger Than the Stick? – The DOJ’s FCPA “Pilot Program”